Having recently completed various technical milestones relating to certain aspects of the business of Ebiox Limited, Keith MacGregor has resigned by mutual consent as Research & Development Director of Ebiox Limited, a subsidiary of Healthcare Enterprise Group (“HCEG”). Mr. MacGregor, an experienced specialist sector professional, will continue to work with HCEG on a consultancy basis, to assist the group with a number of matters. To this end HCEG has allotted to Mr MacGregor 1,475,947 ordinary shares of 2.5p each in the Company, at a price of 4.9 pence per share.

 

Application has been made for the new ordinary shares to be admitted to AIM. The shares are expected to start trading on 25 September 2006, bringing the issued share capital of the Company to 198,183,207.